The Latest Breaking News from US Federal Reserve

Increased health awareness and the rapidly aging population are expected to drive the growth of healthcare companies. Healthcare stocks Cigna Corp. (CI), Humana (HUM), and McKesson Corp. (MCK) have bucked the market downtrend and are in momentum. Since the market is expected to remain under pressure in the near term,…

High-flying tech stocks have faced the brunt of the Federal Reserve’s aggressive interest rate hikes this year. Despite the risk-off environment in equities, fundamentally strong tech stocks which have corrected from their highs offer a great entry point to investors looking to buy and hold for the long term. To…

Congratulations, you just lived through the stock market's worst first half since the Nixon administration.

"Irrational exuberance" is a phrase widely used to warn about the risks of a bubble-like stock market.

Kohl's Corp (NYSE:KSS) has called off discussions to sell its business to Franchise Group Inc (NASDAQ:FRG), CNBC reported. The decision comes at a time when there is increased volatility in the stock market and the economy as the Federal Reserve seeks to hike interest rates to contain inflation. Related: Multiple Bidders, Key Executives Departure, Mixed…

Soaring Inflation and supply chain disruptions have significantly dampened the retail sector’s growth this year. Amid slowing consumer demand, we think investors should invest in Walmart (WMT) since it possesses enough fundamental strength to withstand an economic downturn. On the contrary, Honest Company (HNST) should be avoided now, given its…

Credit Suisse analyst Kevin Mcveigh maintained Paychex, Inc (NASDAQ:PAYX) with an Outperform and cut the price target from $165 to $140. While his view remains overly bullish, he recognizes that the -4% selloff in the PAYX stock was likely due to macroeconomic uncertainty impacting the relative market amid decelerating growth, mainly due to tougher comparisons.…

Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors.

Concerns over the Federal Reserve’s aggressive interest rate hikes to fight elevated inflation and the possibility of the economy tipping into a recession have fostered significant volatility in the market of late. Despite the market uncertainties, Wall Street analysts expect fundamentally sound sub-$5 stocks Provention Bio (PRVB) and Trevi (TRVI)…